痛风患者端粒较短且与发作频率及心血管病相关
该研究在荷兰发现队列(145例痛风患者和273名健康人)及新西兰验证队列(474例痛风和293名健康人)中量化端粒长度,发现痛风患者端粒较健康人短,且端粒长度与痛风发作次数负相关、与心血管病独立相关。
要点
- 痛风患者端粒长度短于健康人,提示细胞衰老加速。
- 痛风患者端粒长度与痛风发作次数呈负相关(p=0.005)。
- 端粒长度是痛风患者心血管病的独立危险因素(p=0.001)。
核心结论
- 痛风患者端粒较健康人短,反映细胞衰老增加。
- 端粒缩短与痛风发作次数及心血管病相关。
研究设计与样本
- 发现队列纳入145例荷兰痛风患者和273名健康人,验证队列纳入474例新西兰痛风患者和293名健康人。
- 通过量化端粒长度评估复制性衰老,并检测多种免疫细胞端粒长度及端粒酶活性。
主要发现
- 健康供者外周血单核细胞端粒长度随时间下降,反映正常衰老。
- 痛风患者端粒较短(p=0.001,R2=0.01873)。
- 痛风患者在任何年龄的端粒侵蚀程度均高于同龄健康人(p<0.0001,R2=0.02847)。
- 合并心血管病的痛风患者端粒最短,端粒长度是痛风患者心血管病的独立危险因素(p=0.001)。
- 端粒长度与痛风发作次数呈负相关(p=0.005)。
临床怎么用
- 端粒长度可能作为痛风患者心血管病风险评估的参考指标。
- 痛风发作频繁者端粒缩短更明显,提示需关注衰老相关并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM AND BACKGROUND: Chronic inflammation associates with increased senescence, which is a strong predictor for cardiovascular disease. We hypothesised that inflammation accelerates senescence and thereby enhances the risk of cardiovascular disease in gout. METHODS: We assessed replicative senescence by quantifying telomere length (TL) in a discovery cohort of 145 Dutch patients with gout and 273 healthy individuals and validated our results in 474 patients with gout and 293 healthy participants from New Zealand. Subsequently, we investigated the effect of cardiovascular disease on TL of all participants. Also, we measured TL of CD4+ and CD8+ T lymphocytes, B lymphocytes, monocytes, natural killer cells and plasmacytoid dendritic cells. Additionally, we assessed the potential temporal difference in TL and telomerase activity. RESULTS: TL in PBMCs of healthy donors decreased over time, reflecting normal ageing. Patients with gout demonstrated shorter telomeres (p=0.001, R2=0.01873). In fact, the extent of telomere erosion in patients with gout was higher at any age compared with healthy counterparts at any age (p<0.0001, R2=0.02847). Patients with gout with cardiovascular disease had the shortest telomeres and TL was an independent risk factor for cardiovascular disease in patients with gout (p=0.001). TL was inversely associated with the number of gouty flares (p=0.005). CONCLUSIONS: Patients with gout have shorter telomeres than healthy participants, reflecting increased cellular senescence. Telomere shortening was associated with the number of flares and with cardiovascular disease in people with gout.
引用
- Vazirpanah N, Kienhorst LBE, Van Lochem E, et al. Patients with gout have short telomeres compared with healthy participants: association of telomere length with flare frequency and cardiovascular disease in gout. Ann Rheum Dis. 2017. PMID: 28347991. doi:10.1136/annrheumdis-2016-210538
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。